Mylet Johanna

CIK 00017659881 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001765988

Recent Transactions

27 trades

Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−35,000→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−80,192→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−111,700→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−72,568→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−65,000→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−4,117→ 0 total
Disposition from Tender
Poseida Therapeutics, Inc.
Common Stock
2025-01-08−254,852→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−82,000→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−125,283→ 0 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-03-01+80,743→ 264,374 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-03-01+111,700→ 111,700 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-03-01$4.13/sh−18,091→ 246,283 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-03-01+92,772→ 181,954 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2023-03-01$5.35/sh−4,323→ 177,631 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-03-01+125,283→ 125,283 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-03-01+50,000→ 84,231 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-03-01+72,568→ 72,568 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-12-21−2,616→ 0 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-12-21−3,100→ 3,816 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-12-21$1.93/sh+3,100→ 34,231 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-12-21$1.17/sh+2,616→ 31,131 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-11-01+65,000→ 65,000 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-04+82,000→ 82,000 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-15−551→ 0 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-15−4,177→ 0 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-01-15$0.30/sh+4,728→ 26,813 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2020-07-09+35,000→ 35,000 total

Companies

Poseida Therapeutics, Inc.
Chief Financial Officer

Recent Filings

Address

C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, STE 200

SAN DIEGO, CA, 92121

View on SEC.gov